How Did The FDA Change In 2021?

Join us for our most popular annual webinar series where we take a closer look at the 483 trends and try to get a deeper understand of the future direction of the FDA.

This session will:
• Summarize the most current publicly-available data on FDA-183 observations issued to pharmaceutical and medical device manufacturers
• Provide a comparative analysis of FDA-483 observations against historical data
• Show how the 483 observation rate provides a window into the FDA’s current thinking about compliance priorities
• Help the attendee to identify high-priority compliance actions that are necessary to avert 483 observations at the next FDA inspection